Bunkerhill MAC vs iCAC Device

Direct competitors — feature-level head-to-head below. Comparability 90/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Bunkerhill MAC

by Bunkerhill Health

iCAC Device

by Bunkerhill Health

AI Verdict

These two FDA-cleared AI tools from Bunkerhill Health are highly comparable, both leveraging AI to analyze routine CT scans for cardiovascular risk identification and integrating with the Carebricks platform. The Bunkerhill MAC tool specifically detects and quantifies mitral annular calcification, while the iCAC Device focuses on detecting and quantifying coronary artery calcium. Therefore, the selection between them depends on the specific cardiovascular marker of interest for risk assessment.

Choose Bunkerhill MAC if…

Choose Bunkerhill MAC if your primary focus is to identify and quantify mitral annular calcification (MAC) from routine CT scans to assess a specific cardiovascular risk factor. This tool is ideal for integrating MAC detection directly into your care coordination workflows through the Carebricks platform, enabling proactive patient management for this particular condition.

View Bunkerhill MAC →

Choose iCAC Device if…

Choose iCAC Device if your goal is to opportunistically detect and quantify coronary artery calcium (CAC) from existing non-contrast chest CT scans to aid in early cardiovascular disease detection. This tool provides valuable adjunctive information to radiologists with precise quantitative estimates of CAC burden, supporting broader cardiovascular risk stratification.

View iCAC Device →

When choosing between Bunkerhill Health’s MAC and iCAC Device AI tools, physicians should consider their primary focus for cardiovascular risk assessment. Both are FDA-cleared AI algorithms from the same company, leveraging routine CT scans for early cardiovascular disease detection and integrating with the Carebricks platform for enhanced clinical workflows. However, their specific applications differ significantly.

The Bunkerhill MAC tool specializes in detecting and quantifying mitral annular calcification (MAC) on routine CT scans. This tool is best suited for cardiologists and radiologists focused on identifying patients at increased cardiovascular risk associated with MAC, facilitating early care coordination. Its key practical difference lies in its specific focus on MAC, a distinct indicator of cardiovascular risk. Physicians prioritizing the identification and management of MAC-related risks would find Bunkerhill MAC more directly applicable to their needs.

Conversely, the Bunkerhill Health iCAC Device is designed to detect and quantify coronary artery calcium (CAC) from routine, non-contrast, non-gated chest CT scans. This tool is ideal for clinicians aiming to assess overall coronary artery disease burden and risk. The key practical difference here is its focus on CAC, a widely recognized marker for atherosclerotic cardiovascular disease. Physicians seeking a broader assessment of coronary risk, particularly for opportunistic screening from existing CT scans, would likely find the iCAC Device to be the more appropriate choice.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Bunkerhill MAC	iCAC Device
Pricing	Contact for pricing	Contact for pricing
Deployment	Cloud-based, integrated with existing EHRs and clinical systems via Carebricks platform.	Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).
FDA Status	Yes AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both Bunkerhill MAC and iCAC Device are developed by Bunkerhill Health and integrate with existing EHRs and clinical systems via the Carebricks platform. This shared integration strategy suggests a consistent and likely similar user experience and deployment process for both tools.

Clinical Value

iCAC Device

Tool B (iCAC Device) detects and quantifies coronary artery calcium (CAC), which is a widely recognized and well-established independent predictor of cardiovascular events with clear clinical guidelines for risk stratification. While Tool A (Bunkerhill MAC) identifies mitral annular calcification (MAC), which is also clinically relevant, CAC has a more extensively validated role in routine cardiovascular risk assessment and management pathways.

Pricing & Value

Tie

Both tools explicitly state 'Contact for pricing' and provide no further details on their cost structure or specific value propositions beyond their clinical utility. Without any comparative pricing information, it is impossible to determine a winner in this dimension.

Enterprise Readiness

Tie

Both tools are FDA-cleared, cloud-based, and designed for integration with existing clinical systems (EHRs, PACS, DICOM routers) via the Carebricks platform. Their compliance statements regarding BAA and HIPAA are also similarly phrased (likely/contact vendor), indicating comparable levels of enterprise readiness from the same vendor.

Innovation

Tie

Both Bunkerhill MAC and iCAC Device leverage AI/deep learning algorithms and integrate with Bunkerhill Health's Carebricks generative AI platform for clinical reasoning and action. Their taglines and descriptions emphasize similar innovative approaches to applying AI in cardiovascular diagnostics.

Support & Docs

Tie

The provided structured facts do not contain any specific information regarding the support services or documentation available for either product. Given that both tools are from the same company and operate within the same platform, it is reasonable to assume a consistent approach to support and documentation across both offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Bunkerhill MAC	iCAC Device
Name	Bunkerhill MAC	iCAC Device
Company	Bunkerhill Health	Bunkerhill Health
Primary Detection Focus	Mitral Annular Calcification (MAC)	Coronary Artery Calcium (CAC)
Scan Type Analyzed	Routine, non-gated chest CT scans	Routine, non-contrast, non-gated chest CT scans
Integration Platform	Carebricks generative AI platform, existing EHRs and clinical systems	PACS or DICOM router, Carebricks platform, EHRs
Key Output/Quantification	AI-powered detection and quantification of Mitral Annular Calcification (MAC)	Estimates presence and quantity of coronary artery calcium (CAC), visual representation of estimated CAC segmentation, exact and four-category quantitative estimates of CAC burden in Agatston units

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill MAC and iCAC Device.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific cardiovascular conditions do these tools help identify?

Bunkerhill MAC detects and quantifies mitral annular calcification (MAC), aiding in early cardiovascular risk identification. The iCAC Device detects and quantifies coronary artery calcium (CAC) to assist in early cardiovascular disease detection.

What types of CT scans are compatible with each tool?

Both Bunkerhill MAC and the iCAC Device analyze routine, non-gated chest CT scans. The iCAC Device specifically analyzes non-contrast, non-gated chest CT images.

How do these tools quantify their respective findings?

Bunkerhill MAC detects and quantifies mitral annular calcification. The iCAC Device provides exact and four-category quantitative estimates of CAC burden in Agatston units, along with a visual representation of estimated CAC segmentation.

How do these tools integrate into existing clinical systems?

Both tools are cloud-based and integrate with existing EHRs and clinical systems via the Carebricks platform. The iCAC Device also integrates as a Software as a Medical Device (SaMD) with PACS or a DICOM router.

What is the primary clinical benefit of using each tool?

Bunkerhill MAC aims to identify patients at increased cardiovascular risk by detecting and quantifying mitral annular calcification, which is often underrecognized. The iCAC Device aids in early cardiovascular disease detection by opportunistically identifying and quantifying coronary artery calcium from existing CT scans.

Are both tools cleared by the FDA?

Yes, both Bunkerhill MAC and the iCAC Device are FDA-cleared AI algorithms.

Do these tools offer automated workflows for follow-up and care coordination?

Bunkerhill MAC supports automated workflows for follow-up and care coordination within the Carebricks platform. The iCAC Device integrates with EHRs via the Carebricks platform, which is designed to automate patient follow-ups and streamline care coordination.